Effects of mycophenolic acid on inosine monophosphate dehydrogenase I and II mRNA expression in white blood cells and various tissues in sheep.

Mycophenolic acid (MPA) is a mycotoxin commonly found as Penicillium genus secondary metabolite in feedstuffs and silages. Feeding with MPA contaminated silages may modulate the immune system in the farm animals and can cause appetite lost, ketosis, paralysis and abortion. The aim of the present study was to characterize the long-term MPA effect on both the inosine monophosphate dehydrogenase (IMPDH) isoforms I and II mRNA expression in white blood cells (WBC) and various tissue of healthy sheep. In treated animals 300 mg MPA/day/sheep was applied. In all investigated tissues the IMPDH I and II mRNA was abundant: WBC, spleen, thymus, ileum, jejunum, kidney, liver, pharyngeal and mesenterial lymph node. An efficiency-corrected relative quantification of the IMPDH types I and II isoforms mRNA were performed by normalizing with the constant reference gene expression of beta-actin. High IMPDH I mRNA expression levels were seen in kidney > mesenterial lymph node > jejunum > spleen > pharyngeal lymph node. Medium and low abundance was found in ileum > WBC > liver > thymus. Type II mRNA was highly expressed in liver > thymus > jejunum. In pharyngeal lymph node > spleen > ileum > mesenterial lymph node > kidney > WBC medium to low IMPDH II mRNA concentrations were detected. Under MPA treatment the IMPDH I mRNA expression was not significantly regulated in WBC, only trends of down- and upregulation were observed. Surprisingly in jejunum an upregulation could be observed (P < 0.05). In pharyngeal lymph node a tendency to downregulation was shown. This may be due to frequent ruminant activities and frequent exposition of MPA to the pharyngeal lymph nodes. In contrast to type I mRNA expression, IMPDH II mRNA was significantly downregulated in ileum (3.4-fold, P < 0.01) and tendencies in downregulation could be seen in jejunum (5.1-fold, P = 0.14). In addition, significant downregulation of IMPDH II gene expression over the entire feeding experiment could be shown in WBC of MPA-treated animals compared with untreated animals (P < 0.05). In conclusion, the recent study demonstrates that feeding sheep with MPA-contaminated silage did not induce IMPDH I mRNA expression in various tissues and blood, except in jejunum, but has suppressive effects on IMPDH II mRNA expression in WBC and ileum.

[1]  M. Hewicker-Trautwein,et al.  Morphological Findings in Lymphatic Tissues of Sheep Following Oral Application of the Immunosuppressive Mycotoxin Mycophenolic Acid , 2005, Mycopathologia.

[2]  U. Germann,et al.  Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes. , 2004, Biochemical pharmacology.

[3]  G. Horgan,et al.  Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR , 2002 .

[4]  M. Harding,et al.  VX-497: a novel, selective IMPDH inhibitor and immunosuppressive agent. , 2001, Journal of pharmaceutical sciences.

[5]  R. Rasmussen.  Quantification on the LightCycler , 2001 .

[6]  M. Pfaffl.  Development and Validation of an Externally Standardised Quantitative Insulin-like Growth Factor-1 RT-PCR Using LightCycler SYBR Green I Technology , 2001 .

[7]  R. Bentley.  Mycophenolic Acid: a one hundred year odyssey from antibiotic to immunosuppressant. , 2000, Chemical reviews.

[8]  J. Bauer,et al.  Mycophenolic Acid in Silage , 2000, Applied and Environmental Microbiology.

[9]  P. Halloran,et al.  The use of mycophenolate mofetil in transplant recipients. , 2000, Immunopharmacology.

[10]  A. Allison,et al.  Mycophenolate mofetil and its mechanisms of action. , 2000, Immunopharmacology.

[11]  M. Sintchak,et al.  The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors. , 2000, Immunopharmacology.

[12]  J. Schnürer,et al.  Molecular Identification of Species from thePenicillium roqueforti Group Associated with Spoiled Animal Feed , 2000, Applied and Environmental Microbiology.

[13]  L. Hedstrom,et al.  Drug selectivity is determined by coupling across the NAD+ site of IMP dehydrogenase. , 2000, Biochemistry.

[14]  J. Caulfield,et al.  Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. , 1999, Transplantation.

[15]  A. Joachimiak,et al.  Differential signatures of bacterial and mammalian IMP dehydrogenase enzymes. , 1999, Current medicinal chemistry.

[16]  A. Dobson,et al.  Mycotoxin production by Aspergillus, Fusarium and Penicillium species. , 1998, International journal of food microbiology.

[17]  E. Oldenburg,et al.  Incidence of Penicillium roqueforti and roquefortine C in silages , 1998 .

[18]  P. Vassalli,et al.  Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL‐12, IFN‐γ, TNF) in the induction of epithelial cell death and renewal , 1998, European journal of immunology.

[19]  G Weber,et al.  Tiazofurin: molecular and clinical action. , 1996, Anticancer research.

[20]  Y. Natsumeda,et al.  Characterization of human type I and type II IMP dehydrogenases. , 1993, The Journal of biological chemistry.

[21]  G. Weber,et al.  Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells. , 1992, Cancer research.

[22]  A. Allison,et al.  Lymphocyte‐Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide Depletion , 1991, Scandinavian journal of immunology.

[23]  K. Suzuki,et al.  Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines. , 1991, The Journal of biological chemistry.